WOCKHARDT LTD.
BSE: 532300
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 561.00+8.7% | 516.00+20.0% | 430.00+13.2% | 380.00-8.0% | 413.00+16.3% | 355.00+9.2% | 325.00-12.2% | 370.00 |
| Other Income | 33.00-40.0% | 55.00+103.7% | 27.00-10.0% | 30.00+20.0% | 25.00+78.6% | 14.00+133.3% | 6.00-45.5% | 11.00 |
| Total Income | 594.00+4.0% | 571.00+24.9% | 457.00+11.5% | 410.00-6.4% | 438.00+18.7% | 369.00+11.5% | 331.00-13.1% | 381.00 |
| EXPENSES | ||||||||
| Expenditure | 487.00+10.9% | 439.00+4.8% | 419.00+17.7% | 356.00-3.5% | 369.00+12.2% | 329.00-6.8% | 353.00-15.3% | 417.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| PROFIT | ||||||||
| PBT | 107.00-35.9% | 167.00+496.4% | 28.00-48.1% | 54.00-21.7% | 69.00+72.5% | 40.00+281.8% | -22.00+38.9% | -36.00 |
| Net Profit | 107.00-35.9% | 167.00+496.4% | 28.00-48.1% | 54.00-21.7% | 69.00+72.5% | 40.00+281.8% | -22.00+38.9% | -36.00 |
| KEY METRICS | ||||||||
| OPM % | 28.16%-9.82pp | 37.98%+14.03pp | 23.95%-5.79pp | 29.74%-1.98pp | 31.72%+1.86pp | 29.86%+66.17pp | -36.31%+2.34pp | -38.65% |
| NPM % | 18.01%-11.24pp | 29.25%+23.12pp | 6.13%-7.04pp | 13.17%-2.58pp | 15.75%+4.91pp | 10.84%+17.49pp | -6.65%+2.80pp | -9.45% |
| EPS | 6.62-35.7% | 10.29+494.8% | 1.73-46.9% | 3.26-23.3% | 4.25+72.1% | 2.47+276.4% | -1.40+40.2% | -2.34 |
Corporate Events
Board MeetingWOCKPHARMA
202610Aug
Board Meeting
The 27th Annual General Meeting will be held to transact ord…
BSE Filing ↗ Board MeetingWOCKPHARMA
20249Aug
Board Meeting
Consider and approve Un-Audited Financial Results (Standalon…
BSE Filing ↗ Board MeetingWOCKPHARMA
202428May
Board Meeting
Consider and approve Audited Financial Results and fund rais…
BSE Filing ↗ Board MeetingWOCKPHARMA
202426Mar
Board Meeting
Consider and approve issue price of Equity Shares
BSE Filing ↗ Board MeetingWOCKPHARMA
202414Feb
Board Meeting
Consider and approve Un-Audited Financial Results (Standalon…
BSE Filing ↗ Board MeetingWOCKPHARMA
202314Nov
Board Meeting
Consider and approve Un-Audited Financial Results (Standalon…
BSE Filing ↗ Board MeetingWOCKPHARMA
202314Aug
Board Meeting
Approval of Unaudited Financial Results (Standalone & Consol…
BSE Filing ↗